Ensartinib

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 165 publications

Expert consensus on iruplinalkib for the treatment of ALK-positive non-small cell lung cancer (2026 edition)

Expert consensus on iruplinalkib for the treatment of ALK-positive non-small cell lung cancer (2026 edition)

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: July 25, 2026

Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.

Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.

Journal: The New England journal of medicine

Published: July 08, 2026

Evolution from KRAS G12C-mutant to ALK fusion-positive stage IV lung adenocarcinoma following immune checkpoint inhibitor therapy: a case report.

Evolution from KRAS G12C-mutant to ALK fusion-positive stage IV lung adenocarcinoma following immune checkpoint inhibitor therapy: a case report.

Journal: Frontiers in oncology

Published: July 06, 2026

Spectrofluorometric and spectrophotometric assay of anticancer drug ensartinib using ion-pair complex formation reaction with eosin Y.

Spectrofluorometric and spectrophotometric assay of anticancer drug ensartinib using ion-pair complex formation reaction with eosin Y.

Journal: Scientific reports

Published: May 22, 2026

Clinical Evaluation of Anaplastic Lymphoma Kinase (ALK) Inhibitors for the First-Line Treatment of Advanced ALK-Positive Non-Small Cell Lung Cancer Based on the 2nd Edition of China's Drug Evaluation and Selection Guideline.

Clinical Evaluation of Anaplastic Lymphoma Kinase (ALK) Inhibitors for the First-Line Treatment of Advanced ALK-Positive Non-Small Cell Lung Cancer Based on the 2nd Edition of China's Drug Evaluation and Selection Guideline.

Journal: Drug design, development and therapy

Published: May 10, 2026

Primary glioblastoma mimicking brain metastasis in ALK-positive lung adenocarcinoma: a case report and literature review.

Primary glioblastoma mimicking brain metastasis in ALK-positive lung adenocarcinoma: a case report and literature review.

Journal: Frontiers in oncology

Published: March 24, 2026

Repurposing ALK inhibitors as influenza and corona virus antivirals targeting lymphocyte tyrosine kinase (LTK).

Repurposing ALK inhibitors as influenza and corona virus antivirals targeting lymphocyte tyrosine kinase (LTK).

Journal: Virus research

Published: March 13, 2026

Repurposing ALK Inhibitors as Influenza and Corona Virus Antivirals Targeting Lymphocyte Tyrosine Kinase (LTK).

Repurposing ALK Inhibitors as Influenza and Corona Virus Antivirals Targeting Lymphocyte Tyrosine Kinase (LTK).

Journal: Virus research

Published: March 13, 2026

Identification of a novel ALK intergenic fusion in a resected high‑recurrence‑risk lung adenocarcinoma and adjuvant treatment with ensartinib: a case report.

Identification of a novel ALK intergenic fusion in a resected high‑recurrence‑risk lung adenocarcinoma and adjuvant treatment with ensartinib: a case report.

Journal: Frontiers in oncology

Published: March 09, 2026

Ensartinib Combined with Radiotherapy for the Treatment of Advanced Primary  Pulmonary Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring  TPM3-ALK Fusion: A Case Report

Ensartinib Combined with Radiotherapy for the Treatment of Advanced Primary  Pulmonary Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring  TPM3-ALK Fusion: A Case Report

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: March 04, 2026

Cost of managing brain metastases in ALK-positive advanced NSCLC patients receiving first-line ALK TKIs in China.

Cost of managing brain metastases in ALK-positive advanced NSCLC patients receiving first-line ALK TKIs in China.

Journal: Lung cancer management

Published: February 03, 2026

Long-term outcomes of ALK inhibitors in metastatic ALK-positive non-small cell lung cancer: an updated indirect comparison using reconstructed patient-level data.

Long-term outcomes of ALK inhibitors in metastatic ALK-positive non-small cell lung cancer: an updated indirect comparison using reconstructed patient-level data.

Journal: Translational lung cancer research

Published: January 18, 2026

Showing 1-12 of 165

Last Updated: 09/26/2026